Trends in Prices, Market Share, and Spending on Self-administered Disease-Modifying Therapies for Multiple Sclerosis in Medicare Part D

IMPORTANCE: Before 2009, only 4 self-administered disease-modifying therapies (DMTs) were approved for the treatment of multiple sclerosis (MS). Since then, 7 new agents have entered the market. OBJECTIVE: To assess trends in prices, market share, and spending on self-administered DMTs for MS in Med...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:JAMA Neurol
Main Authors: San-Juan-Rodriguez, Alvaro, Good, Chester B., Heyman, Rock A., Parekh, Natasha, Shrank, William H., Hernandez, Inmaculada
Formato: Artigo
Idioma:Inglês
Publicado em: American Medical Association 2019
Assuntos:
Brief Report
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6714023/
https://ncbi.nlm.nih.gov/pubmed/31449293
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamaneurol.2019.2711
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados